| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.2M | +175.1% |
| SG&A Expense | $10.8M | -37.0% |
| Operating Income | -$18.1M | +55.5% |
| Interest Expense | $31.8M | -19.0% |
| Pre-tax Income | -$49.8M | +37.6% |
| Income Tax | $0 | — |
| Net Income | -$49.8M | +37.6% |
| EPS (Basic) | -$0.05 | +50.0% |
| EPS (Diluted) | -$0.05 |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | +22.4% |
| Inventory | $0 | — |
| Current Assets | $10.8M | +0.1% |
| Total Assets | $11.1M | -1.4% |
| Current Liabilities | $84.2M | -29.7% |
| Long-term Debt | $45.0M | -1.6% |
| Total Liabilities | $127.9M | +5.9% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | +56.3% |
| Financing Cash Flow | $11.7M | -60.7% |
| +50.0% |
| Stockholders' Equity |
| -$116.8M |
| -6.6% |